Last reviewed · How we verify

NCT05351476

Exercise Training and Fat Metabolism in Postmenopausal Women

Recruiting now NA Last updated 13 April 2026
What this trial tests

NA trial testing Resistance Exercise in Postmenopausal Symptoms in 120 participants. Currently enrolling.

Timeline
20 May 2022
Primary endpoint
30 April 2027
30 April 2027

Quick facts

Lead sponsorFlorida State University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposebasic science
Enrollment120
Start date20 May 2022
Primary completion30 April 2027
Estimated completion30 April 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Florida State University

Who can join

Adults 50 to 75, female only, with Postmenopausal Symptoms or Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Adipose tissue turnover plays a critical role in body weight maintenance, and obesity is underscored by the dysregulated balance between fat breakdown and synthesis. Although there are clear health-related benefits of physical activity, little is known about how resistance exercise, as opposed to endurance exercise, can reduce the risk of metabolic disorders, particularly in women. The goal of the proposed study is to investigate the effectiveness of resistance training to improve basal and stimulated fat metabolism in postmenopausal women with obesity and pre-diabetes, potentially serving as a viable and practical approach to prevent the onset of type 2 diabetes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Resistance Exercise

Trials testing the same drug.

Other recruiting trials for Postmenopausal Symptoms

Currently open trials in the same condition.

Other Florida State University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05351476.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing